|
CCDC122 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.053900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.572300E-02 |
| Normal-vs-Stage2 |
3.694600E-01 |
| Normal-vs-Stage3 |
2.717600E-01 |
| Normal-vs-Stage4 |
9.113400E-01 |
| Stage1-vs-Stage2 |
8.024000E-01 |
| Stage1-vs-Stage3 |
5.297200E-03 |
| Stage1-vs-Stage4 |
3.329800E-01 |
| Stage2-vs-Stage3 |
1.049760E-01 |
| Stage2-vs-Stage4 |
5.641000E-01 |
| Stage3-vs-Stage4 |
4.169000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.195800E-02 |
| Normal-vs-AfricanAmerican |
5.485400E-01 |
| Normal-vs-Asian |
5.462000E-02 |
| Caucasian-vs-AfricanAmerican |
1.190160E-01 |
| Caucasian-vs-Asian |
1.970210E-02 |
| AfricanAmerican-vs-Asian |
6.308400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.837700E-02 |
| Normal-vs-Female |
3.046600E-01 |
| Male-vs-Female |
4.956600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.355600E-01 |
| Normal-vs-Extreme_Weight |
5.616100E-02 |
| Normal-vs-Obese |
1.083440E-01 |
| Normal-vs-Extreme_Obese |
5.842000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.470600E-01 |
| Normal_Weight-vs-Obese |
3.526400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.342400E-01 |
| Extreme_Weight-vs-Obese |
8.263800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.718600E-01 |
| Obese-vs-Extreme_Obese |
6.474600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.442200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.999500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.765230E-01 |
| Normal-vs-Age(81-100Yrs) |
7.723000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.598700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.259700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.664200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.626300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.034000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.186400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.175600E-04 |
| Normal-VS-Type2 PRCC |
5.211600E-01 |
| Normal-VS-KIRP CIMP |
3.5148999999457E-06 |
| Normal-VS-Unclassified PRCC |
5.703800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.62960000005263E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.63419999754666E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
5.507800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.36500000033924E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.917000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.11560002849609E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.224400E-01 |
| Normal-vs-N1 |
4.203000E-01 |
| Normal-vs-N2 |
1.880380E-01 |
| N0-vs-N1 |
4.224600E-01 |
| N0-vs-N2 |
2.290600E-01 |
| N1-vs-N2 |
2.138400E-01 |
|
|
